Drug Profile
Research programme: RAD51 inhibitors - Cyteir Therapeutics
Alternative Names: CYT 0853; CYT 1027; CYT 1127; CYT-02ALatest Information Update: 08 May 2023
Price :
$50
*
At a glance
- Originator Cyteir Therapeutics
- Class Antihyperglycaemics; Antineoplastics; Small molecules
- Mechanism of Action Rad51 recombinase modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Autoimmune disorders; B-cell lymphoma; Leukaemia; Type 1 diabetes mellitus